Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine
- 19 June 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 341 (8860) , 1545-1550
- https://doi.org/10.1016/0140-6736(93)90693-b
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Optimal schedule for the administration of oral poliovirus vaccinePublished by Springer Nature ,1993
- Inactivated and live, attenuated poliovirus vaccines: mucosal immunityPublished by Springer Nature ,1993
- Polio Eradication From the Western HemisphereAnnual Review of Public Health, 1992
- Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated DiseaseClinical Infectious Diseases, 1992
- Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated childrenThe Lancet, 1991
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991
- A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.American Journal of Public Health, 1989
- CLINICAL EFFICACY OF A NEW, ENHANCED-POTENCY, INACTIVATED POLIOVIRUS VACCINEThe Lancet, 1988
- RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZILThe Lancet, 1988
- Cost Effectiveness of Alternative Strategies for Poliomyelitis Immunization in BrazilClinical Infectious Diseases, 1984